Pennant Group and Hartford HealthCare strengthen their collaboration to enhance home-based care services in Connecticut.
Quiver AI Summary
The Pennant Group, Inc. and Hartford HealthCare announced an expansion of their strategic partnership aimed at enhancing home-based care services in Connecticut. This collaboration, which began in May 2024, focuses on setting new industry standards and improving patient outcomes through innovation. Both organizations have made significant strides, including achieving Hartford HealthCare at Home's first-ever 4-star rating from CMS and enhancing clinical quality while expanding patient access. The partnership will continue to strengthen by creating a unified operating entity for home-based care, emphasizing the importance of delivering high-quality care in patients' homes. Leaders from both organizations expressed pride in their accomplishments and a commitment to improving healthcare accessibility and affordability for local communities.
Potential Positives
- The collaboration with Hartford HealthCare has resulted in improved clinical outcomes, reflected in Hartford HealthCare at Home achieving its first-ever 4-star CMS rating.
- The partnership has expanded access for patients, enabling the delivery of life-changing care to tens of thousands of patients through hundreds of thousands of visits.
- The mutual investment in home-based care demonstrates a commitment to innovation and excellence, positioning the Pennant Group as a leader in home care delivery nationally.
Potential Negatives
- The press release does not disclose specific financial details or performance metrics related to The Pennant Group, which may raise concerns about the overall financial health and transparency of the company.
- While there are claims of improved clinical outcomes and operational performance, there is no independent verification included in the release to support these assertions, potentially undermining credibility.
- The collaboration's transition into a unified operating entity may indicate existing challenges that necessitated this strategic evolution, hinting at potential operational inefficiencies or issues in the current model.
FAQ
What is the purpose of the collaboration between Pennant Group and Hartford HealthCare?
The collaboration aims to strengthen and expand home-based care services across Connecticut, setting new standards for home care delivery.
When did the partnership between Pennant Group and Hartford HealthCare begin?
The partnership began in May 2024, reflecting a commitment to innovation and excellence in home care services.
What have been the outcomes of the Pennant and Hartford HealthCare collaboration?
The collaboration improved clinical outcomes, expanded patient access, and enhanced operational performance, achieving a 4-star CMS rating for Hartford HealthCare at Home.
How does the partnership impact home care innovation?
The partnership implements proven systems and technologies, driving innovation in home health and hospice services, enhancing patient care.
What is the long-term goal of the Pennant-Hartford collaboration?
The goal is to redefine home care in Connecticut, ensuring exceptional care delivery while improving access and affordability for patients.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PNTG Insider Trading Activity
$PNTG insiders have traded $PNTG stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $PNTG stock by insiders over the last 6 months:
- BRENT GUERISOLI (Chief Executive Officer) has made 0 purchases and 4 sales selling 4,508 shares for an estimated $158,139.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$PNTG Revenue
$PNTG had revenues of $285.4M in Q1 2026. This is an increase of 35.99% from the same period in the prior year.
You can track PNTG financials on Quiver Quantitative's PNTG stock page.
You can access data on PNTG stock through the Quiver Quantitative API.
$PNTG Hedge Fund Activity
We have seen 90 institutional investors add shares of $PNTG stock to their portfolio, and 106 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- 8 KNOTS MANAGEMENT, LLC removed 1,732,850 shares (-99.5%) from their portfolio in Q4 2025, for an estimated $48,779,727
- WASATCH ADVISORS LP added 835,227 shares (+143.2%) to their portfolio in Q1 2026, for an estimated $25,457,718
- OPHIR ASSET MANAGEMENT PTY LTD removed 422,969 shares (-31.9%) from their portfolio in Q1 2026, for an estimated $12,892,095
- QUBE RESEARCH & TECHNOLOGIES LTD removed 411,140 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $12,531,547
- ALGERT GLOBAL LLC removed 352,642 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $10,748,528
- WCM INVESTMENT MANAGEMENT, LLC removed 327,483 shares (-50.0%) from their portfolio in Q1 2026, for an estimated $9,981,681
- WOODLINE PARTNERS LP removed 318,948 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $9,721,535
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$PNTG Analyst Ratings
Wall Street analysts have issued reports on $PNTG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/07/2026
- William Blair issued a "Outperform" rating on 12/08/2025
To track analyst ratings and price targets for $PNTG, check out Quiver Quantitative's $PNTG forecast page.
$PNTG Price Targets
Multiple analysts have issued price targets for $PNTG recently. We have seen 3 analysts offer price targets for $PNTG in the last 6 months, with a median target of $42.0.
Here are some recent targets:
- Stephen Baxter from Wells Fargo set a target price of $41.0 on 05/08/2026
- Ben Hendrix from RBC Capital set a target price of $42.0 on 05/08/2026
- David Macdonald from Truist Securities set a target price of $42.0 on 05/08/2026
Full Release
EAGLE, Idaho, June 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care, and senior living companies, and Hartford HealthCare, a leading integrated health system serving Connecticut, announced the next evolution of their strategic collaboration to strengthen and expand home-based care services across Connecticut.
From the outset in May 2024, this partnership has reflected a shared commitment to innovation and excellence. Together, the organizations are laying the groundwork to become a nationally recognized model of home care: one that sets new standards, inspires advancement across the continuum of care, and delivers meaningful outcomes for both patients and providers.
Building on this strong foundation, Hartford HealthCare and The Pennant Group are further strengthening their collaboration through mutual investment in home-based care in Connecticut, with plans to transition it into a unified, forward-looking operating entity.
Since the collaboration began, Hartford HealthCare and Pennant have worked together to enhance clinical quality, expand patient access, and strengthen operational performance across HHCAH — helping position the organization as a leading model for home-based care delivery.
The collaboration between Pennant and Hartford HealthCare has:
- Improved clinical outcomes, as well as operational performance, reflected in Hartford HealthCare at Home’s first-ever 4-star Centers for Medicare & Medicaid Services rating.
- Implemented proven systems and Pennant’s leading-edge industry technologies, driving innovation in home health and hospice.
-
Expanded access for patients while delivering life-changing care to tens of thousands of patients through hundreds of thousands of visits.
“We are honored by the trust Hartford HealthCare has placed in Pennant and proud of the progress we’ve achieved together during the initial management period,” said Brent Guerisoli, Chief Executive Officer of Pennant. “Over the last two years, we have had a meaningful impact on quality, expanded access, improved patient outcomes, and advanced the long-term financial sustainability of homecare at HHC. This collaboration is a natural next step, and it underscores the strength of Pennant’s model to create scalable, high-performing home care operations that deliver high caliber value for patients, partners, the community and shareholders.”
“Home care is one of the most personal and impactful ways we serve our communities, and the progress we’ve made together is extraordinary. Over the past two years, Hartford HealthCare at Home has achieved its first-ever 4-star CMS rating, expanded access to thousands of more patients, and strengthened outcomes through innovation and collaboration. These results reflect the dedication of our teams and the power of collaboration between two leading healthcare organizations,” said Eric Smullen, Executive Vice President of Hartford HealthCare at Home. “We are doubling down on our commitment to deliver exceptional care where patients feel most comfortable at home and setting a new standard for home health in Connecticut. “As healthcare continues to evolve, the most affordable and effective care is often delivered in the home. Investing in home-based care enables us to better manage chronic conditions, improve access, and lower costs while maintaining exceptional quality.”
“Pennant is proud to deepen our alignment with the exceptional team at Hartford HealthCare as we work together to redefine what home care can be in Connecticut,” said John Gochnour, Pennant’s President and Chief Operating Officer. “Hartford HealthCare’s reputation for excellence and commitment to patient-centered care aligns perfectly with our mission. Through this collaboration, we will continue to strengthen a continuum of care that truly makes a difference for patients and families across the state. The new arrangement will continue to empower home care colleagues to serve local communities and provide exceptional care to the patients and families entrusted to them.”
About Pennant
:
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Alabama, Arizona, California, Colorado, Connecticut, Georgia, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at
www.pennantgroup.com
.
About Hartford HealthCare
With 48,000 dedicated colleagues and a bold vision for the future, Hartford HealthCare is transforming healthcare across Connecticut and beyond, enhancing access, affordability, health equity, and excellence. Spanning more than 500 locations across 185 towns and cities, our comprehensive care-delivery system is built to serve every community, every day.
From world-class hospitals, including two tertiary-level teaching hospitals, an acute-care community teaching hospital, an acute-care hospital and trauma center, and four community hospitals, to an expansive network of behavioral health services, multispecialty physician groups, urgent and virtual care, surgery centers, home care, senior care, rehabilitation, and mobile neighborhood health programs, Hartford HealthCare is there when and where it matters most.
Hartford HealthCare touches the lives of more than 28,000 people every single day, delivering unparalleled care through its unique Institute Model, bringing together leading experts in neuroscience, cancer, digestive health, heart and vascular care, orthopedics, and urology and kidney health to provide a unified, high standard of care at the most affordable cost.
Recognized nationally for patient safety and clinical excellence, Hartford HealthCare was the only health system in the country awarded the prestigious Quest for Quality Prize from the American Hospital Association. A national leader in patient safety, Hartford HealthCare also earned ‘A’ Hospital Safety Grades from The Leapfrog Group across all its hospitals in 2023 and 2024, reflecting a long-standing commitment to providing safe, high-quality care.
Join us on our journey to redefine healthcare.
Visit www.HartfordHealthCare.org and stay connected through our newsletters and social media.
SOURCE: The Pennant Group, Inc.